Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction

Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction

(2011) Giulio Guagliumi et al.   CIRCULATION

Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents

(2011) Lorenz Räber et al.   CIRCULATION

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Bioresorbable Scaffold

(2011) Yosinobu Onuma et al.   CIRCULATION

Four-Year Follow-Up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty)

(2011) Christian Spaulding et al.   JACC-Cardiovascular Interventions

Very Late Stent Thrombosis After Primary Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction

(2011) Bruce Brodie et al.   JACC-Cardiovascular Interventions

5-Year Follow-Up After Primary Percutaneous Coronary Intervention With a Paclitaxel-Eluting Stent Versus a Bare-Metal Stent in Acute ST-Segment Elevation Myocardial Infarction

(2011) Maarten A. Vink et al.   JACC-Cardiovascular Interventions

Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study

(2011) Peter Herbison et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

(2011) Pieter C. Smits et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial

(2011) Gregg W Stone et al.   LANCET

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

(2011) Giulio G Stefanini et al.   LANCET

Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study

(2011) Maurits Dirksen et al.   EuroIntervention

Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study

(2011) Jael Atary et al.   EuroIntervention

Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

(2011) Manel Sabaté et al.   EuroIntervention

Does “late catch-up” exist in drug-eluting stents: Insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents

(2010) Kyung Woo Park et al.   AMERICAN HEART JOURNAL

Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study)

(2010) Jael Z. Atary et al.   AMERICAN JOURNAL OF CARDIOLOGY

Role of the Paclitaxel-Eluting Stent and Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Postfibrinolysis Angioplasty

(2010) Pedro L. Sánchez et al.   Circulation-Cardiovascular Interventions

Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

(2010) Anne Kaltoft et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Selection Criteria for Drug-Eluting Versus Bare-Metal Stents and the Impact of Routine Angiographic Follow-Up

(2010) Gregg W. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction

(2010) Roberto Violini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

(2010) Lisette Jensen et al.   EuroIntervention

Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina—Comparison of the effects of drug-eluting versus bare-metal stents

(2009) Gregor Leibundgut et al.   AMERICAN HEART JOURNAL

Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial

(2009) Emilio Di Lorenzo et al.   AMERICAN HEART JOURNAL

Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction

(2009) Akiko Maehara et al.   CIRCULATION

The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial

(2009) Emilio Di Lorenzo et al.   JACC-Cardiovascular Interventions

Incomplete Stent Apposition and Delayed Tissue Coverage Are More Frequent in Drug-Eluting Stents Implanted During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Than in Drug-Eluting Stents Implanted for Stable/Unstable Angina

(2009) Nieves Gonzalo et al.   JACC-Cardiovascular Interventions

Mechanisms of Late Stent Malapposition After Primary Stenting in ST-Elevation Myocardial Infarction: A Subanalysis of the Selection Trial

(2009) TANIA CHECHI et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

The 5-Year Clinical Outcomes After a Randomized Comparison of Sirolimus-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

(2009) Matteo Tebaldi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of Drug-Eluting Stents in Acute Myocardial Infarction

(2009) Somjot S. Brar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials

(2009) Giuseppe De Luca et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction

(2009) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale

(2008) Roxana Mehran et al.   AMERICAN HEART JOURNAL

Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort

(2008) Pieter J. Vlaar et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group

(2008) Bruce R. Brodie et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction

(2008) Henning Kelbæk et al.   CIRCULATION

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients

(2008) Gaku Nakazawa et al.   CIRCULATION

Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

(2008) Neville Kukreja et al.   Circulation-Cardiovascular Interventions

Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial InfarctionThe MULTISTRATEGY Randomized Trial

(2008) Marco Valgimigli   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Drug-Eluting Stent Thrombosis

(2008) José M. de la Torre-Hernández et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: 9-Month Angiographic and Intravascular Ultrasound Results and 12-Month Clinical Outcome

(2008) Bas L. van der Hoeven et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction

(2008) Laura Mauri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

(2008) Lesley Wood et al.   BMJ-British Medical Journal